2026-09-16 12:59:00 UTC#320815newconfirmednews
Cellectis S.A. stock news
Cellectis S.A. stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire10 wire items
2026-09-15 17:33:18 UTC#315867duplicateconfirmednews
Cellectis shares decline following Citizens downgrade to Market Perform
2026-09-15 12:53:00 UTC#313870newconfirmednews
Wells Fargo maintains Cellectis at Equal-Weight, cuts price target to $3.00 from $4.00
2026-09-15 12:40:00 UTC#313759newconfirmednews
Cellectis (CLLS) downgraded to Market Perform from Market Outperform at Citizens
2026-09-14 13:23:35 UTC#307616duplicateconfirmednews
Cellectis (ALCLS) pivots to in vivo gene editing, discontinues cell therapy programs, extends runway to 2028
2026-09-14 11:21:00 UTC#306830duplicateconfirmednews
Cellectis shares fall 27% as company pivots to in vivo gene editing, halts CAR T-cell pipeline
2026-09-11 20:39:03 UTC#300792newconfirmeddata release
Cellectis reports GAAP EPS of -$0.39 and revenue of $14.45M
2026-08-07 08:16:46 UTC#143365duplicateconfirmednews
Cellectis S.A. reports Q2 adjusted loss of $0.22 per share on $6.9M revenue
2026-08-06 21:16:06 UTC#140534newconfirmednews
Cellectis Q2 GAAP EPS -$0.22 beats by $0.04, Revenue $6.9M misses by $3.93M
2026-08-04 14:47:05 UTC#123848newforecastnews